Inactive Instrument
Poseida Therapeutics, Inc. Stock
Stocks
PSTX
US73730P1084
Biotechnology & Medical Research
| 1 day | -0.63% |
| 3 years | 1.83 |  | 9.67 |
| 5 years | 1.54 | | 9.67 |
| 10 years | 1.54 | | 17.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dara Pincas
CEO | Chief Executive Officer | - | - |
Johanna Mylet
DFI | Director of Finance/CFO | 39 | 2020-06-30 |
Syed Rizvi
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 2025-01-07 |
Roger Brown
BRD | Director/Board Member | - | 2025-01-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/8/25 | Tender | Director | 190,300 | 0.1952% | ||
| 1/8/25 | Tender | Director | 141,500 | 0.1452% | ||
| 1/8/25 | Tender | Company | 11,835,673 | 12.1435% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.63% | -.--% | - | - | 929M | |
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | |
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | |
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | |
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | |
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | |
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | |
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | |
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | |
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | |
| Average | +0.18% | +2.41% | +48.08% | +140.89% | 42.57B | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.02% | +142.84% |
Employees
350
